Phase II study of lapatinib and tegafur combination efficacy for the treatment of HER2+ metastatic breast cancer.
Alexey Manikhas
No relevant relationships to disclose
Ineza O. Sharvashidze
No relevant relationships to disclose
Tatjana N. Kotkova
No relevant relationships to disclose